Literature DB >> 12622773

Population of the HLA ligand database.

M Sathiamurthy1, H D Hickman, J W Cavett, A Zahoor, K Prilliman, S Metcalf, M Fernandez Vina, W H Hildebrand.   

Abstract

We have established an HLA ligand database to provide scientists and clinicians with access to Major Histocompatibility Complex (MHC) class I and II motif and ligand data. The HLA Ligand Database is available on the world wide web at http://hlaligand.ouhsc.edu and contains ligands that have been published in peer-reviewed journals. HLA peptide datasets prove useful in several areas: ligands are important as targets for various immune responses while algorithms built upon ligand datasets allow identification of new peptides without time-consuming experimental procedures. A review of the HLA class I ligands in the database identifies strengths and deficiencies in the database and, therefore, the utility of the dataset for identifying new peptides. For instance, 212 HLA-A phenotypes exist of which 23 have a motif determined and 43 have peptides characterized. In terms of number of ligands, HLA-A*0201 has 258 characterized ligands, A*1101 has 25 peptides, while the remaining two-thirds of the HLA-A phenotypes have less than 10 associated peptide sequences. Characterization of ligands and motifs remains roughly the same at the HLA-B locus while the peptides of the HLA-C locus tend to be less characterized. These data show that 74% of HLA class I molecules do not have ligands represented in the database and thus algorithms based on the dataset could not predict ligands for a majority of the US population. Building upon this dataset and knowledge of HLA allelic frequencies, it is possible to plan a systematic expansion of the HLA class I ligand database to better identify ligands useful throughout the population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622773     DOI: 10.1034/j.1399-0039.2003.610102.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  25 in total

1.  Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.

Authors:  Gema Díaz; Benito Cañas; Jesús Vazquez; César Nombela; Javier Arroyo
Journal:  Immunogenetics       Date:  2004-11-24       Impact factor: 2.846

2.  ANCA patients have T cells responsive to complementary PR-3 antigen.

Authors:  Jiajin Yang; David J Bautz; Sofia Lionaki; Susan L Hogan; Hyunsook Chin; Roland M Tisch; John L Schmitz; Barrak M Pressler; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

3.  Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.

Authors:  G Ramadan; B Davies; V P Kurup; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

4.  Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein.

Authors:  Ruben Varela-Calvino; Ania Skowera; Sefina Arif; Mark Peakman
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens.

Authors:  Edvina Gregoric; Jurji Avramovic Gregoric; Fabrizio Guarneri; Salvatore Benvenga
Journal:  Endocrine       Date:  2011-02       Impact factor: 3.633

6.  Human self-protein CD8+ T-cell epitopes are both positively and negatively selected.

Authors:  Michal Almani; Shai Raffaeli; Tal Vider-Shalit; Lea Tsaban; Vered Fishbain; Yoram Louzoun
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

Review 7.  Design and utilization of epitope-based databases and predictive tools.

Authors:  Nima Salimi; Ward Fleri; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2010-03-06       Impact factor: 2.846

8.  Autoimmune thyroid disease elicited by NY-ESO-1 vaccination.

Authors:  Roberto Vita; Fabrizio Guarneri; Ravin Agah; Salvatore Benvenga
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

9.  Viruses selectively mutate their CD8+ T-cell epitopes--a large-scale immunomic analysis.

Authors:  Tal Vider-Shalit; Ronit Sarid; Kobi Maman; Lea Tsaban; Ran Levi; Yoram Louzoun
Journal:  Bioinformatics       Date:  2009-06-15       Impact factor: 6.937

10.  Phase-dependent immune evasion of herpesviruses.

Authors:  Tal Vider-Shalit; Vered Fishbain; Shai Raffaeli; Yoram Louzoun
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.